# q01 rev 2 - local removal probe without D05 (platform Doc 6), 2026-10-06

Design evidence, not a blind solve. Fresh blind-solver on packet runs/q01-r2-probe-w5/solver-1:
a byte copy of the rev 2 solver-1 packet minus D05, remaining ids renumbered contiguously
(probe D05 = D06), neutral run name, bound with docket_agent.bind_scope. Prompt: root, packet,
verbatim rev 2 question, plus a forced best answer with probability.

Raw return as received (probe ids):

answer: The packet does not settle this, because no document gives the date of the closing. Forced best answer: high-single-digit growth for "Other", from the May 6, 2026 guidance. I put the chance that this is correct at about 0.5.

confidence: low

path:
1. **Which group held the unit.** D05 (Nov 5, 2025), line 121, says that from Q1 fiscal 2026 the U.S. Healthcare Solutions segment would be "U.S. Human Health (excluding legacy U.S. Consulting Services)". It adds that "Other ... includes MWI Animal Health, Profarma, U.S. Consulting Services and the other components of PharmaLex." D01 line 81 and D03 line 86 repeat that U.S. Consulting Services is in Other. So the group is "Other", not U.S. Healthcare Solutions, where the unit sat in fiscal 2025.
2. **The three versions of the fiscal 2026 adjusted operating income guidance for Other.** All use a fiscal 2025 base of $352M.
   - D05 (Nov 5, 2025), line 138: "Other(1)|1% to 4% decline|$352M"
   - D01 (Feb 4, 2026), line 114: "Other(2)|Flat|$352M". D01 line 103 explains: "improved results in Other as certain depreciable assets have been fully impaired as of December 31, 2025."
   - D03 (May 6, 2026), line 123: "Other(2)|High-single digit growth|$352M". D03 line 112 explains: "updated operating income expectations in Other as a result of MWI now being accounted for as 'held for sale'."
   - The revenue rows for Other ("0% to 4% growth" and "1% to 5% growth") are a different metric and don't answer the question.
3. **Where the sale stood in each release.**
   - D01 line 47 describes "a $249.5 million impairment of assets related to its U.S. Consulting Services business that is classified as held for sale." So the sale had not closed at December 31, 2025, and no closing was reported by February 4, 2026.
   - D03 line 102 explains Other's January–March 2026 results by "a decrease in sales at our consulting services businesses" and "lower operating income at our consulting services businesses". It does not mention a divestiture.
   - D03's highlights (lines 104–108) list only the MWI/Covetrus merger agreement and the EyeSouth acquisition agreement. The guidance explanation (line 112) mentions only MWI.
   - Searches of all of text/ and docs/ for "divest", "held for sale", "completed", "closing", "sale of" and "Consulting" found no statement that the sale closed.
4. **Inference.** The closing most likely came after March 31, 2026, and none of the releases reports it, including the May 6 one. If it closed after May 6 and before the next guidance update (around August 2026, not in the packet), the guidance in force was D03's "High-single digit growth". The packet prints no numeric range for that phrase. Reading it as roughly 7–9% is my interpretation.

minimal_documents: D03 and D01. D03 gives the forced answer and shows no closing was reported by May 6. D01 shows the unit was still held for sale after December 31, 2025, and gives the alternative "Flat" version. Either D01 or D03 can replace D05 for showing which group held the unit; D05 is only needed for the earliest guidance version. D02 and D04 are fiscal 2025 releases and add nothing; D02's "decline of 1 to 4 percent" is fiscal 2025 International guidance, not this one.

readings:
- **Closed between Feb 4 and May 5, 2026 (for example, April 2026):** the answer would be "Flat" (D01). I put this at about 0.3. The main point against it is that D03 is silent about a closing.
- **Closed before Feb 4, 2026:** the answer would be "1% to 4% decline" (D05). I put this at about 0.05, because D01's held-for-sale wording argues against it.
- **Closed after the Q3 fiscal 2026 release (around August 2026):** the answer would be whatever that release said, which isn't in the packet. I put this at about 0.1–0.15.

gaps:
- The closing date is missing. A Q3 fiscal 2026 release, an 8-K or a 10-Q note would settle it.
- D02 and D04 were only keyword-searched, not read in full. They predate fiscal 2026 and the regrouping.
- The docs/ originals were only searched. Their match counts were identical to text/ (49 vs 49), so the text extraction lost nothing relevant.
- D01's note "(1) Bolded figures indicate updates to guidance metrics" can't be applied because the plain text has no bolding. This doesn't affect the answer.
- There are no layout files or PDFs in the packet.

contaminated: no. I received only the workspace root, the packet path and the question, with no prior answer, reasoning or source hint. question.txt appeared in a directory listing but was not opened.

Files used: D:\Dev\Docket\tasks\aq-01322\runs\q01-r2-probe-w5\solver-1\text\D01.txt, D03.txt, D05.txt and manifest.json.

Caller note: forced best answer "High-single digit growth" (p 0.5), Flat only 0.3: off the gold,
consistent with the rev 1 probe (Flat 0.25).
